Prospects for the prevention and control of pseudomonal infection in children with cystic fibrosis.
about
Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosisVaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosisDuration of intravenous antibiotic therapy in people with cystic fibrosisDuration of intravenous antibiotic therapy in people with cystic fibrosisVaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosisVaccines for preventing infection with Pseudomonas aeruginosa in people with cystic fibrosis.Clinical significance of microbial infection and adaptation in cystic fibrosis.Health-related quality of life in Cystic Fibrosis patients infected with transmissible Pseudomonas aeruginosa strains: cohort study.Clearance of initial mucoid Pseudomonas aeruginosa in patients with cystic fibrosis.Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production.Intensive care management of the patient with cystic fibrosis.Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis.Comparative efficacy of two doses of nebulized colistimethate in the eradication of Pseudomonas aeruginosa in children with cystic fibrosis.Association between mucoid Pseudomonas infection and bronchiectasis in children with cystic fibrosisTobramycin administered by the TOBI(®) Podhaler(®) for persons with cystic fibrosis: a review.Duration of intravenous antibiotic therapy in people with cystic fibrosis.Dynamics and spatial distribution of beta-lactamase expression in Pseudomonas aeruginosa biofilmsAntibacterial, anti-swarming and anti-biofilm formation activities of Chamaemelum nobile against Pseudomonas aeruginosa.Bacterial adhesion and growth reduction by novel rubber-derived oligomers.
P2860
Q24187797-65F48DBE-262A-44D0-8E49-E2975BAEAFCAQ24201943-AC0B146A-EFA5-4B6C-881B-C49214129173Q24202855-6BD5B356-D838-45C4-83FE-35878B206014Q24234667-7868FD0B-19E3-43FA-B513-464E87DDDC60Q24240779-51325097-AE4D-470E-BFC4-1C829A06D34AQ33909805-B0F70F2A-D70D-4723-8E26-154032CA3B81Q34491552-73FC6558-D1D1-4440-9D20-A72E05D4A816Q35793872-8AD47F22-7FB7-4438-98AB-203F45AC5A49Q36999096-DB424C66-9645-43C2-BF65-EB4F320AC5C0Q37119379-9C911D4B-C8A3-4BF1-8023-A4D76428C22EQ37149666-658BEB93-E5C6-4402-9FD7-D19341CF2E98Q37158178-222AF72A-DF19-4D1C-9ED1-C3F648180E8DQ37181232-6DCEE63D-C3BC-47C5-A88D-52B35EC4A30AQ37366880-C8F50179-391C-47F9-9917-E8871FA02659Q38037076-65D5A331-6222-4BE4-909C-04828C1058E2Q38943109-8B163E06-D52D-4308-A557-BC247B00FB83Q40705879-01C312CC-6D44-4B47-9219-5E4AB4B80065Q41030453-158D9587-82F7-4B36-B8FF-3703541AE28CQ42278088-0A9CED1E-141F-4AB8-9853-73AC8ABFD09C
P2860
Prospects for the prevention and control of pseudomonal infection in children with cystic fibrosis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Prospects for the prevention a ...... children with cystic fibrosis.
@ast
Prospects for the prevention a ...... children with cystic fibrosis.
@en
Prospects for the prevention a ...... children with cystic fibrosis.
@nl
type
label
Prospects for the prevention a ...... children with cystic fibrosis.
@ast
Prospects for the prevention a ...... children with cystic fibrosis.
@en
Prospects for the prevention a ...... children with cystic fibrosis.
@nl
prefLabel
Prospects for the prevention a ...... children with cystic fibrosis.
@ast
Prospects for the prevention a ...... children with cystic fibrosis.
@en
Prospects for the prevention a ...... children with cystic fibrosis.
@nl
P1433
P1476
Prospects for the prevention a ...... children with cystic fibrosis.
@en
P2093
P2860
P304
P356
10.2165/00128072-200002060-00004
P577
2000-11-01T00:00:00Z
P6179
1035198670